Abstract
The present study evaluated the effects of both intraperitoneal (i.p.) and intracerebroventricular administration of selective Y 1 [(Leu 31, Pro 34)-NPY] and Y 2 [(Pro 13, Tyr 36)-NPY (13–36)] receptor agonists on food intake in satiated goldfish. Food intake (FI) was significantly increased by central administration of the Y 1 agonist (1 μg), but not by the Y 2 agonist, at 2 h postinjection. The feeding increase induced by (Leu 31, Pro 34)-NPY was in a similar magnitude to that obtained after ICV injection of the neuropeptide Y, and both feeding stimulations were reversed by the NPY (27–36), a general NPY antagonist. The i.p. administration of the agonists either did not significantly modify (Y 2 agonist) or decreased (Y 1 agonist) food intake in goldfish. These data indicate that it is the Y 1-like (similar to Y 1 and/or Y 5) receptor, and not Y 2, that is involved in the central modulation of the feeding behavior in goldfish. We also investigated the possible involvement of opioid peptides as mediators of the NPY stimulatory action on food intake in goldfish. The ICV administration of naloxone (10 μg), a general opioid antagonist, blocked the NPY-induced feeding in goldfish, suggesting that the opioidergic system is involved in feeding regulation by NPY.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.